Developer docs
API playgroundTry for free, no card

Search company profiles

Pregna International

Full company profile

uuid00031tz

Namestring
Pregna International
Legal namestring
Pregna International Ltd.
Websiteurl
pregna.com
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Pregna International Ltd., founded in 1991 and headquartered in Mumbai, India, is a privately held medical device manufacturer focused on women's reproductive health and contraception. The company's core technology is intrauterine contraception, spanning two families: (i) the Eloira levonorgestrel-releasing intrauterine system (IUS), a hormonal device with a 52mg hormone reservoir and rate-controlling membrane delivering approximately 20 mcg/day for up to five years and a claimed 99.8% effectiveness rate, and (ii) a broad copper-bearing IUD portfolio including Pregna Copper T 380A, the Inara series (Cu 375, Cu 375 Sleek, Cu 250), the Silverline silver-core series (Cu 380 Ag and Cu 200 Ag and mini variants), Copper Y Cu 380 and Mini, Safeload, Etherena, Pregna+, Aureline Gold, and Yanae. Beyond IUDs/IUS, Pregna offers tubal rings for female sterilization, a postpartum IUD (PPIUD), the CryoPop cryotherapy device, the Endometrial Biopsy Curette (EBC) and ancillary products (Esa uterine sound, UBT).

The company self-positions as the world's largest manufacturer of intrauterine contraceptive devices, with over 100 million IUDs sold cumulatively across 140+ countries. Revenue is generated via direct hardware sales through a sales-led, B2B/B2G go-to-market — selling to distributors, hospitals, healthcare systems, and government family planning programs — with multi-year procurement contracts and pricing by direct inquiry rather than published list pricing. End-customers are women of reproductive age served via physicians, gynecologists, hospitals, and public-sector family planning channels; Pregna supports demand with provider education, IEC catalog materials, and consumer/clinical content via its website and social channels. Ownership is founder/management-led with a minority growth investment from InvAscent's India Life Sciences Fund III (Rs 130 crore / ~$16M, June 2023).

Short descriptiontext

Pregna International is a Mumbai-based medical device manufacturer, founded in 1991, of intrauterine contraceptive devices and hormonal intrauterine systems, distributed across 140+ countries through B2B/B2G channels serving hospitals, healthcare providers, and government family planning programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMumbai, India
HQ citystring
Mumbai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
intrauterine device manufacturing, hormonal contraceptive devices, copper IUD products, female sterilization devices, women reproductive health
Industry3 codes
PRIMARYHLAKAJAG
Family Planning & Contraception (Including Abortion Care)
SECONDARYHLAIACAN
Women’s Health & Reproductive Specialty Pharmaceuticals
SECONDARYHLAKAJAJ
Sexual & Reproductive Health (STI Care, Vulvovaginal Disorders)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Contraceptive Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Pregna International generates revenue primarily through the sale of intrauterine contraceptive devices and women's reproductive health products to healthcare providers, distributors, and institutional buyers globally.

pregna.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1B2B/B2G institutional sales - pricing through direct inquiry
ModelOtherBilling cadenceMulti-year contract
Notes

Product pricing available through direct sales inquiry; institutional and government procurement typically handled through quotes and contracts.

pregna.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Eloira
Description

Hormonal contraceptive intrauterine system (IUS) containing Levonorgestrel, marketed as a reversible contraceptive with 99.8% effectiveness rate.

pregna.com
+6 more records
Core offering1 text field

Pregna International manufactures and globally distributes a portfolio of intrauterine contraceptive devices, including hormonal intrauterine systems (Eloira levonorgestrel IUS), copper-based IUDs (Inara, Silverline, Copper T 380A, Copper Y, Pregna+, Etherena), postpartum IUDs, and tubal rings for female sterilization. The company also produces complementary gynecological devices such as CryoPop cryosurgical equipment and the Endometrial Biopsy Curette, sold to healthcare providers, hospitals, and public health programs across more than 140 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 99.8% effectiveness rate for hormonal contraceptive (Eloira)
+1 more record
Product overview1 text field

Pregna International is a global manufacturer of women's reproductive health solutions, offering a comprehensive portfolio of intrauterine devices and systems. The product portfolio includes two main categories: (1) Intrauterine Systems (IUS) - hormonal contraceptive devices like Eloira containing levonorgestrel hormone; and (2) Intrauterine Devices (IUD) - copper-based contraceptives including various models such as Safeload, Inara series (Cu 375, Cu 375 Sleek, Cu 250), Silverline series (Cu 380 Ag, Cu 200 Ag), Pregna Copper T 380A, Pregna+, Etherena, Copper Y devices, and Post Partum IUD. Additional offerings include Tubal Rings for female sterilization, CryoPop for cryosurgery, Endometrial Biopsy Curette (EBC), UBT, Aureline Gold IUD, and Yanae. The company positions itself as the world's largest IUD manufacturer with 100 million IUDs sold across 140 countries.

Product and service9 records
1Eloira Levonorgestrel Intrauterine System (IUS)
CategoryHormonal Contraceptive Devices
Description

Hormonal intrauterine system containing 52 mg levonorgestrel in a hormone reservoir with rate-controlling membrane; releases approximately 20 micrograms of levonorgestrel per day into the uterine cavity, effective for up to 5 years with a 99.8% effectiveness rate. Sold to healthcare providers and public health programs for long-term reversible contraception.

2Inara Cu 375 IUD
CategoryCopper IUDs
Description

Copper bearing intrauterine device providing long-term reversible contraception for women. Sold to healthcare providers and distributors globally.

3Inara Cu 375 Sleek IUD
CategoryCopper IUDs
Description

Slim profile variant of the Inara Cu 375 copper IUD designed for enhanced insertion comfort while providing long-term reversible contraception.

4Inara Cu 250 IUD
CategoryCopper IUDs
Description

Copper bearing IUD with lower copper surface area for long-term reversible contraception in women.

5Cu 250 Sleek IUD
CategoryCopper IUDs
Description

Slim profile copper intrauterine device for long-term reversible contraception.

6Silverline Cu 380 Ag IUD
CategoryCopper IUDs
Description

Long-term reversible intrauterine device with a silver core and copper surface, providing contraception for up to 10 years.

7Silverline Cu 200 Ag IUD
CategoryCopper IUDs
Description

Silver-core copper intrauterine device with moderate copper surface area for long-term reversible contraception.

8Silverline Cu 380 Ag Mini IUD
CategoryCopper IUDs
Description

Compact version of the Silverline silver-core copper IUD designed for women with smaller uterine cavities, providing long-term reversible contraception.

9Pregna Copper T 380A IUD
CategoryCopper IUDs
Description

T-shaped copper intrauterine device providing long-term reversible contraception for up to 10 years.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CooperSurgical markets PARAGARD, the leading copper IUD in the U.S., and offers a portfolio of OB/GYN devices and consumables. Directly competes with Pregna's copper IUD line (Copper T 380A, Inara, Silverline) for institutional tenders globally.

TypeBroad incumbent
Description

Viatris holds women's health assets including oral contraceptives and generic hormonal products with global distribution. Competes with Pregna in the broader contraceptive category, particularly on hormonal product lines targeting emerging markets.

TypeDirect peer
Description

DKT International is one of the largest private providers of contraception and reproductive health products in the developing world, with manufacturing and distribution across 60+ countries. Directly comparable to Pregna as a contraceptive manufacturer-distributor targeting emerging-market family planning programs.

TypeBroad incumbent
Description

Spun out of Merck in 2021, Organon is a women's health-focused pharma with established contraceptive brands and global commercial reach. Competes with Pregna across hormonal contraception and family planning institutional channels.

TypeBroad incumbent
Description

MSD operates a global women's health franchise including contraceptive implants (Implanon/Nexplanon) and IUDs. Competes with Pregna for OB/GYN share of voice and institutional family planning budgets.

TypeEmerging player
Description

SMB and similar Indian/Asian contract manufacturers produce generic IUDs and women's health devices for global brands. Comparable to Pregna on manufacturing capabilities and emerging-market distribution.

TypeBroad incumbent
Description

Teva is a major generic pharmaceutical manufacturer with significant women's health and contraceptive offerings globally. Comparable as a broad incumbent competing for institutional family planning contracts.

8HLL Lifecare Limited
TypeRegional player
Description

HLL Lifecare is an Indian government-owned contraceptive and healthcare products manufacturer with a broad portfolio including condoms, IUDs, and blood bags. Comparable to Pregna as a domestic Indian manufacturer competing for public-sector family planning procurement, though with broader product scope.

TypeEmerging player
Description

Mona Lisa is a Belgian manufacturer of copper IUDs with global distribution focus on family planning programs. Comparable to Pregna as a focused copper IUD manufacturer competing in the same institutional tender market.

TypeBroad incumbent
Description

Bayer's Mirena, Kyleena, Liletta, and Skyla levonorgestrel IUS franchise is the global hormonal IUD market leader. Directly competes with Pregna's Eloira IUS on clinical positioning, prescriber relationships, and pricing in both developed and emerging markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pregna International

Contraceptive Medical Devicespregna.com

Pregna International is a Mumbai-based medical device manufacturer, founded in 1991, of intrauterine contraceptive devices and hormonal intrauterine systems, distributed across 140+ countries through B2B/B2G channels serving hospitals, healthcare providers, and government family planning programs.

What Pregna International does

Pregna International Ltd., founded in 1991 and headquartered in Mumbai, India, is a privately held medical device manufacturer focused on women's reproductive health and contraception. The company's core technology is intrauterine contraception, spanning two families: (i) the Eloira levonorgestrel-releasing intrauterine system (IUS), a hormonal device with a 52mg hormone reservoir and rate-controlling membrane delivering approximately 20 mcg/day for up to five years and a claimed 99.8% effectiveness rate, and (ii) a broad copper-bearing IUD portfolio including Pregna Copper T 380A, the Inara series (Cu 375, Cu 375 Sleek, Cu 250), the Silverline silver-core series (Cu 380 Ag and Cu 200 Ag and mini variants), Copper Y Cu 380 and Mini, Safeload, Etherena, Pregna+, Aureline Gold, and Yanae. Beyond IUDs/IUS, Pregna offers tubal rings for female sterilization, a postpartum IUD (PPIUD), the CryoPop cryotherapy device, the Endometrial Biopsy Curette (EBC) and ancillary products (Esa uterine sound, UBT).

The company self-positions as the world's largest manufacturer of intrauterine contraceptive devices, with over 100 million IUDs sold cumulatively across 140+ countries. Revenue is generated via direct hardware sales through a sales-led, B2B/B2G go-to-market — selling to distributors, hospitals, healthcare systems, and government family planning programs — with multi-year procurement contracts and pricing by direct inquiry rather than published list pricing. End-customers are women of reproductive age served via physicians, gynecologists, hospitals, and public-sector family planning channels; Pregna supports demand with provider education, IEC catalog materials, and consumer/clinical content via its website and social channels. Ownership is founder/management-led with a minority growth investment from InvAscent's India Life Sciences Fund III (Rs 130 crore / ~$16M, June 2023).

Pregna International firmographics

Firmographics
Name
Pregna International
Legal name
Pregna International Ltd.
Website
https://pregna.com
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
101–250 employees
Short description
Pregna International is a Mumbai-based medical device manufacturer, founded in 1991, of intrauterine contraceptive devices and hormonal intrauterine systems, distributed across 140+ countries through B2B/B2G channels serving hospitals, healthcare providers, and government family planning programs.
Ownership category
akta.pro rank

Pregna International industry classification

Industry
Product category
Contraceptive Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAKAJAG
Family Planning & Contraception (Including Abortion Care)
SECONDARYHLAIACAN
Women’s Health & Reproductive Specialty Pharmaceuticals
SECONDARYHLAKAJAJ
Sexual & Reproductive Health (STI Care, Vulvovaginal Disorders)

Keywords

  • Intrauterine device manufacturing
  • Hormonal contraceptive devices
  • Copper IUD products
  • Female sterilization devices
  • Women reproductive health

Where Pregna International is headquartered

Location

Headquarters

HQ city
Mumbai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Pregna International business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Medical Device Sales: Pregna International generates revenue primarily through the sale of intrauterine contraceptive devices and women's reproductive health products to healthcare providers, distributors, and institutional buyers globally.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractB2B/B2G institutional sales - pricing through direct inquiry

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Pregna International product offering

Product offering

Core offering

Pregna International manufactures and globally distributes a portfolio of intrauterine contraceptive devices, including hormonal intrauterine systems (Eloira levonorgestrel IUS), copper-based IUDs (Inara, Silverline, Copper T 380A, Copper Y, Pregna+, Etherena), postpartum IUDs, and tubal rings for female sterilization. The company also produces complementary gynecological devices such as CryoPop cryosurgical equipment and the Endometrial Biopsy Curette, sold to healthcare providers, hospitals, and public health programs across more than 140 countries.

Product overview

Pregna International is a global manufacturer of women's reproductive health solutions, offering a comprehensive portfolio of intrauterine devices and systems. The product portfolio includes two main categories: (1) Intrauterine Systems (IUS) - hormonal contraceptive devices like Eloira containing levonorgestrel hormone; and (2) Intrauterine Devices (IUD) - copper-based contraceptives including various models such as Safeload, Inara series (Cu 375, Cu 375 Sleek, Cu 250), Silverline series (Cu 380 Ag, Cu 200 Ag), Pregna Copper T 380A, Pregna+, Etherena, Copper Y devices, and Post Partum IUD. Additional offerings include Tubal Rings for female sterilization, CryoPop for cryosurgery, Endometrial Biopsy Curette (EBC), UBT, Aureline Gold IUD, and Yanae. The company positions itself as the world's largest IUD manufacturer with 100 million IUDs sold across 140 countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Eloira: Hormonal contraceptive intrauterine system (IUS) containing Levonorgestrel, marketed as a reversible contraceptive with 99.8% effectiveness rate.
  • Inara
  • Silverline
  • Yanae
  • Safeload
  • Etherena
  • CryoPop

Products and services

  • Eloira Levonorgestrel Intrauterine System (IUS) Hormonal intrauterine system containing 52 mg levonorgestrel in a hormone reservoir with rate-controlling membrane; releases approximately 20 micrograms of levonorgestrel per day into the uterine cavity, effective for up to 5 years with a 99.8% effectiveness rate. Sold to healthcare providers and public health programs for long-term reversible contraception.
  • Inara Cu 375 IUD Copper bearing intrauterine device providing long-term reversible contraception for women. Sold to healthcare providers and distributors globally.
  • Inara Cu 375 Sleek IUD Slim profile variant of the Inara Cu 375 copper IUD designed for enhanced insertion comfort while providing long-term reversible contraception.
  • Inara Cu 250 IUD Copper bearing IUD with lower copper surface area for long-term reversible contraception in women.
  • Cu 250 Sleek IUD Slim profile copper intrauterine device for long-term reversible contraception.
  • Silverline Cu 380 Ag IUD Long-term reversible intrauterine device with a silver core and copper surface, providing contraception for up to 10 years.
  • Silverline Cu 200 Ag IUD Silver-core copper intrauterine device with moderate copper surface area for long-term reversible contraception.
  • Silverline Cu 380 Ag Mini IUD Compact version of the Silverline silver-core copper IUD designed for women with smaller uterine cavities, providing long-term reversible contraception.
  • Pregna Copper T 380A IUD T-shaped copper intrauterine device providing long-term reversible contraception for up to 10 years.

Quantifiable outcome

  • 99.8% effectiveness rate for hormonal contraceptive (Eloira)
  • +1 more outcomes

Companies that use Pregna International

Customer profile

Segments2 records

Ideal customer profiles3 records

Pregna International technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Pregna International partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Pregna International competitors and assessment

Company assessment

Direct peers

  • CooperSurgical (PARAGARD): CooperSurgical markets PARAGARD, the leading copper IUD in the U.S., and offers a portfolio of OB/GYN devices and consumables. Directly competes with Pregna's copper IUD line (Copper T 380A, Inara, Silverline) for institutional tenders globally.
  • DKT International: DKT International is one of the largest private providers of contraception and reproductive health products in the developing world, with manufacturing and distribution across 60+ countries. Directly comparable to Pregna as a contraceptive manufacturer-distributor targeting emerging-market family planning programs.

Broad incumbents

  • Viatris (formerly Mylan): Viatris holds women's health assets including oral contraceptives and generic hormonal products with global distribution. Competes with Pregna in the broader contraceptive category, particularly on hormonal product lines targeting emerging markets.
  • Organon: Spun out of Merck in 2021, Organon is a women's health-focused pharma with established contraceptive brands and global commercial reach. Competes with Pregna across hormonal contraception and family planning institutional channels.
  • MSD (Merck & Co.) Women's Health: MSD operates a global women's health franchise including contraceptive implants (Implanon/Nexplanon) and IUDs. Competes with Pregna for OB/GYN share of voice and institutional family planning budgets.
  • Teva Pharmaceutical Industries: Teva is a major generic pharmaceutical manufacturer with significant women's health and contraceptive offerings globally. Comparable as a broad incumbent competing for institutional family planning contracts.
  • Bayer (Women's Health / Mirena): Bayer's Mirena, Kyleena, Liletta, and Skyla levonorgestrel IUS franchise is the global hormonal IUD market leader. Directly competes with Pregna's Eloira IUS on clinical positioning, prescriber relationships, and pricing in both developed and emerging markets.

Emerging players

  • SMB Corporation (SMB Pharma / Fareva): SMB and similar Indian/Asian contract manufacturers produce generic IUDs and women's health devices for global brands. Comparable to Pregna on manufacturing capabilities and emerging-market distribution.
  • Mona Lisa N.V. Mona Lisa is a Belgian manufacturer of copper IUDs with global distribution focus on family planning programs. Comparable to Pregna as a focused copper IUD manufacturer competing in the same institutional tender market.

Regional players

  • HLL Lifecare Limited: HLL Lifecare is an Indian government-owned contraceptive and healthcare products manufacturer with a broad portfolio including condoms, IUDs, and blood bags. Comparable to Pregna as a domestic Indian manufacturer competing for public-sector family planning procurement, though with broader product scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Pregna International social profiles

Digital presence

Pregna International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pregna International leadership team

Management profile

Number of profiles

Profiles1 record

Pregna International funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pregna International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pregna International

What does Pregna International do?

Pregna International manufactures and globally distributes a portfolio of intrauterine contraceptive devices, including hormonal intrauterine systems (Eloira levonorgestrel IUS), copper-based IUDs (Inara, Silverline, Copper T 380A, Copper Y, Pregna+, Etherena), postpartum IUDs, and tubal rings for female sterilization. The company also produces complementary gynecological devices such as CryoPop cryosurgical equipment and the Endometrial Biopsy Curette, sold to healthcare providers, hospitals, and public health programs across more than 140 countries.

Is Pregna International a public or private company?

Pregna International is a private company. It is classified as venture growth investor backed and is currently operating.

When was Pregna International founded?

Pregna International was founded in 1996. It employs 101 to 250 people.

Where is Pregna International based?

Pregna International is headquartered in Mumbai, India, in the Asia region.

How does Pregna International make money?

One revenue line is on record: medical Device Sales.

Who are Pregna International's main competitors?

Direct peers on record are CooperSurgical (PARAGARD) and DKT International. Broad incumbents are Viatris (formerly Mylan), Organon, MSD (Merck & Co.) Women's Health, Teva Pharmaceutical Industries and Bayer (Women's Health / Mirena). Emerging players are SMB Corporation (SMB Pharma / Fareva) and Mona Lisa N.V.. HLL Lifecare Limited is listed as a regional player.

Does Pregna International have an API?

No public API is recorded for Pregna International.

What industry is Pregna International in?

Pregna International's product category is Contraceptive Medical Devices. Its primary akta.pro industry code is HLAKAJAG, Family Planning & Contraception (Including Abortion Care), with a secondary code of HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comUnited States Contraceptive Devices Market to Reach US$ 5.81 Billion by 2033 | Top Companies - CooperSurgical, Inc., Pregna International Limited, Reckitt Benckiser Group | Exclusive report by DataM iThe United States contraceptive devices market is projected to reach US$5.81 billion by 2033, driven by innovations and increased awareness. Major companies like CooperSurgical, Pregna International, and Reckitt Benckiser are actively expanding and deploying new manufacturing technologies to improve safety and accessibility.PR NewswirePain Management Segment Dominates Cryosurgery Devices Market - Musculoskeletal Disorders Propel GrowthResearchAndMarkets.com published a report projecting the global cryosurgery devices market to grow at a CAGR of over 6.5% during 2023-2028, driven by rising prevalence of chronic disorders and musculoskeletal conditions affecting approximately 1.71 billion people worldwide. The pain management segment is expected to hold a significant market share as cryosurgery devices gain traction for treating chronic pain, with North America anticipated to dominate due to advanced healthcare infrastructure and high demand for minimally invasive surgery. Notable product developments include Pregna International's launch of a CO-2-based cryotherapy device for cervical cancer and ArtiCure Inc.'s FDA clearance for cryo nerve block therapy for adolescent patients, though stringent regulatory guidelines and reimbursement issues may restrain market growth.The Times of Indiataparia: Women’s contraceptive products maker Pregna International raises Rs 130 crore from India Life Sciences Fund - The Economic TimesPregna International raised Rs 130 crore ($16 million) in its first private equity funding round from India Life Sciences Fund III for a minority stake. The capital will be used to strengthen the company's manufacturing capabilities and expand its portfolio of reproductive health products globally. Unaprime Investment Advisors acted as the exclusive financial advisor for this transaction.